IceCure Medical
Manufacturing · Israel · 51-200 Employees
View Company Info for Free
Overview
Headquarters
7 Ha'eshel St, Caesarea, Haifa, 3079504,...Phone Number
+972 46230333Website
www.icecure-medical.comRevenue
<$5 MillionStock Symbol
ICCMIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
2
1
1
1
1
1
About IceCure Medical
IceCure Medical Ltd. is an Israeli medical device company that develops, manufactures, and markets minimally-invasive cryoablation systems used to destroy benign and malignant tumors by freezing them. Its flagship ProSense liquid-nitrogen-based technology offers a safe and effective alternative to traditional surgical tumor removal. The company's products are used worldwide in a range of clinical applications across women's health and interventional oncology, with regulatory approvals in multiple regions and a growing global distribution network. IceCure was incorporated in 2006 and is headquartered in Caesarea, Israel.Explore more
IceCure Medical Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is IceCure Medical your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Check out if IceCure Medical is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at IceCure Medical
IceCure Medical, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if IceCure Medical had a recent Job posting/layoffs
Funding: Get notified immidiatlly once IceCure Medical has new funding data
Product Launch: Get notified when IceCure Medical launches new products
Earning: See what the market has to say on IceCure Medical recently announced quarterly report
Check if IceCure Medical has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Reach out to Masked Content who joined IceCure Medical as Masked Content
Find more new buyers
Company Profile Activity
Activity Insights
IceCure Medical is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
IceCure Medical is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about IceCure Medical.
IceCure Medical financials insights
Gather financial insights about IceCure Medical, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Stock Offering
$6.1M
IceCure Medical Tech Stack
A closer look at the technologies used by IceCure Medical
Most Recent Scoops
New Hire
Executive Move
Executive Moves, New Hire
Project
Laboratory Operations, Medical Research, Clinical Operations
New Hire
Executive Move
Executive Moves, New Hire
Earnings
Event
Earnings, Events, Finance
Earnings
Earnings, Finance
IceCure Medical News & Media
IceCure Medical Kicks Off its Post-Marketing "ChoICE" Study for the Low-Risk Breast Cancer Treatment at First U.S Clinical Site
Company signed agreement with the West Cancer Center & Research Institute, the first clinical site for its post-marketing study for ProSense® cryoablation in the treatment of low-risk breast cancer CAESAREA, Israel, July 27, 2026 /PRNewswire/ -- IceCure Medical Ltd. (Nasdaq: ICCM)...IceCure Expands U.S. Commercial Team to Meet Surging Demand for ProSense® Cryoablation
CAESAREA, Israel, July 14, 2026 /PRNewswire/ -- IceCure Medical Ltd. (Nasdaq: ICCM) ("IceCure," "IceCure Medical" or the "Company"), developer of minimally-invasive liquid nitrogen-based cryoablation technology that destroys tumors by freezing as an option to surgical tumor removal, today...IceCure Highlights Expanding Commercial Adoption of ProSense™ Cryoablation in Brazil Following FDA Clearance for Breast Cancer
Growing physician interest and commercial adoption for ProSense™ in Brazil's expanding interventional oncology markets increased following FDA authorization Independent study evaluating breast cancer cryoablation in 750 patients across Brazil, led by renowned breast surgeon Dr. Vanessa...IceCure Highlights New Peer-Reviewed Journal Article in Leading Surgery Journal, Demonstrating Cryoablation's Advantages Over Radiofrequency Ablation for Early-Stage Breast Cancer
Published in the International Journal of Surgery, globally ranked in the top three among surgery journals, the article highlights strong clinical outcomes with ProSense® cryoablation and describes thermal ablation as a "beacon of hope for patients IceCure preparing for the 2026 Japanese...
Read more news
Top Manufacturing Companies
Top companies in Australia by revenue
Frequently Asked Questions Regarding IceCure Medical
Sign Up For FreeTo access detailed company insights
IceCure Medical Ltd. is an Israeli medical device company that develops, manufactures, and markets minimally-invasive cryoablation systems used to destroy benign and malignant tumors by freezing them. Its flagship ProSense liquid-nitrogen-based technology offers a safe and effective alternative to traditional surgical tumor removal. The company's p... Read More
